| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Gritstone bio, Inc. | Director | Common Stock | 0 | $47,560 | $1.90 | 04 Apr 2025 | Direct |
| Nabriva Therapeutics plc | Director | Ordinary Shares | 11,447 | $17,171 | $1.50 | 02 Aug 2022 | Direct |
| Cullinan Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 38,513 | 12 Jun 2025 | Direct | ||
| NextCure, Inc. | Director | Stock Option (Right to Buy) | 18,700 | 20 Jun 2025 | Direct | ||
| Gritstone bio, Inc. | Director | Stock Option (Right to Buy) | 0 | 04 Apr 2025 | Direct | ||
| TCR2 THERAPEUTICS INC. | Director | Stock Option (Right to Buy) | 0 | $0.7400 | 01 Jun 2023 | Direct |